Delegates Premium Access

Impact of sodium-glucose cotransporter-2 inhibitors on survival in patients with cancer therapy-related cardiac dysfunction

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Congress Presentation

About the speaker

Associate Professor Reza Arsanjani

Mayo Clinic, Scottsdale (United States of America)
0 follower

5 more presentations in this session

Effect of statin on right ventricle function in breast cancer patients treated with anthracycline

Speaker: Associate Professor K. Mindadze (Tbilisi, GE)

Thumbnail

Gliflozines in active cancer patients with heart failure: final results on safety and effectiveness in the observational TOSCA trial

Speaker: Doctor I. Fabiani (Pisa, IT)

Thumbnail

Revisiting the role of angiotensin-converting enzyme inhibitors in preventing chemotherapy cancer related cardiac disease in paediatric malignant bone tumours patients

Speaker: Professor Z. Seliem (Cairo, EG)

Thumbnail

Sacubitril/Valsartan and cardiovascular outcomes in cancer patients on anthracycline therapy: a global health research network retrospective analysis

Speaker: Doctor L. Gioli-Pereira (Sao Paulo, BR)

Thumbnail

Prevention of radiation induced cardiotoxicity in patients with left sided breast cancer: results from a phase 2 clinical trial

Speaker: Doctor I. Paterson (Ottawa, CA)

Thumbnail

Access the full session

Novel strategies for prevention in cardio-oncology

Speakers: Associate Professor R. Arsanjani, Associate Professor K. Mindadze, Doctor I. Fabiani, Professor Z. Seliem, Doctor L. Gioli-Pereira...
Thumbnail

About the event

Image

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations